Novo Nordisk’s weight-loss drug Wegovy has been surpassed in weekly U.S. prescriptions by Eli Lilly’s Zepbound, and now the ...

Four leading organizations in lifestyle medicine, obesity medicine, and nutrition-the American College of Lifestyle Medicine ...

A new study suggests that urban environments may influence how impulsivity disorders like ADHD contribute to the obesity ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, May 28, 2025 (HealthDay News) — Popular GLP-1 weight loss drugs like Ozempic ...

The data showed that kids who don’t see their BMI decline between ages 1 and 6 have a greater risk of obesity. This risk was ...

Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find ...

Adopting a healthy lifestyle that includes plenty of physical activity and a low fat diet is a necessary step when waging the ...

Viking Therapeutics faces tough obesity drug rivals, with VK2735 showing promise but an uncertain edge. Find out why VKTX ...

The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.

Metabolic-associated fatty liver disease is prevalent in children and adolescents with severe obesity, with higher insulin ...

Turkey has launched a nationwide campaign to measure citizens’ weight in public to combat its rising obesity rates — a move ...